Introduction: Acute renal allograft rejection is define as a sudden decline in the function of the transplanted kidney that gives rise to the creatinine levels. Whenever acute rejection is confirmed, the possibility of inadequate immunosuppression, whether due to inadequate dosing or noncompliance, must be addressed. The failure to recognize this contributing factor increases the risk of continued acute rejection episodes and, due to inadequate longterm immunosuppression, may eventually lead to graft failure. However, there is not a pre-defined protocol available to predict the probability of an adverse event in patients receiving the same medications. Moreover a more personalized immunosuppressive therapy may prevent complications and help to avoid graft rejection. Several Single Nucleotide Polymorphisms (SNPs) have been already associated with acute renal allograft rejection (AR). Therefore we aim to identify a pre-operative SNP profile assay that might underline the differences in the genetic background of the patients. SNPs are analyzed for allele and genotype frequencies in genes involved in immune responses and pharmacokinetics/pharmacodynamics of immunosuppressive drugs.
Methods: This is a cohort study. Genomic DNA isolated from 200 ml of whole blood of 153 kidney transplant patients (42 with AR (wAR) and 111 without AR (w/oAR)) are genotyped for 20 SNPs in TNF-alpha, IL-10, ABCB1, UGT1A9, IMPDH2 genes. Results: The average age of our kidney transplanted patients is 52.8 years and their group consists of 48 females and 105 males. Based on our preliminary results all SNPs are in Hardy-Weinberg equilibrium (HWE) in our study population. No transplant patients wAR were C/C homozygote for ABCB1 G-2677T/A, T/T and C/C homozygotes for UGT1A9 C-440T and T-331C, respectively. In our ongoing study so far 9 SNPs have been analyzed by Trend Test between the two transplanted groups; the p values are above 0.05 for each SNP, with the exception for UGT1A9 C-440T and T-331C (p ¼ 0.043). The allele frequencies of C for UGT1A9 C-440T and T for UGT1A9 T-331C are both 70% in the w/oAR group; while, the allele frequencies of those polymorphisms are increased to 83% in the wAR group. Conclusions: The homozygotes T/T and C/C for UGT1A9 C-440T and T-331C are missing in the wAR group and may define a possible protective haplotype for patients w/oAR. However, analyzing the composition of the two transplant groups there is a statistically significant difference for gender. Thus, to confirm our results a case-control, multicenter research study is needed. Data from the newly enrolled patients will allow us to perform an age-and sexmatched analysis of the patients' cohort. Understanding the exact link between these SNPs and acute kidney rejection is crucial to more successfully maximalize antirejection therapies. Further analysis of these specific profiles suggests that DLE, which is less associated with renal involvement, demonstrates repression of inflammatory pathways which could predict protection from renal disease. Contrarily, sCLE, which is associated with a higher risk of lupus nephritis, shares overlapping gene regulation involving dendritic cells which may identify this cellular population as essential to disease development for both skin and renal disease. These data may identify important molecular targets for novel therapies in cutaneous and renal lupus.
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